FDA approves Isentress at a higher dose for HIV-1 infected patients.
A new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.
AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.
Lilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.
FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
A new study led by The University of California researchers and published in JAMA reveals surprising findings.
Based on new data from 2 large clinical trials, FDA is warning that these blockbuster type 2 diabetes medications can cause an increased risk of leg and foot amputations.
FDA expanded the use of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to treat cystic fibrosis.